
    
      This is a monocentric prospective cohort study in which 100 patients treated for malignant
      tumors and with cardiac radiation exposure will be included.All patient will be followed for
      12 months after radiotherapy. Echocardiography, 2D STE parameters and circulating biomarkers
      will be collected.
    
  